Cellid, COVID-19 vaccine Korean stock

13 ส.ค. 2020Bullish

Reasons
- Cup & handle formation
- Bounces on trendline
- Currently developing COVID-19 vaccine in Korea alongside other biotech products
- Korean government granted $30 mil to develop vaccines recently

29 ส.ค. 2020

การซื้อขายยังคงดำเนินอยู่

Prices pulled back from the initial trendline due to choppiness from falling KOSDAQ index. This was due to fears of economic shutdown from COVID-19 breakouts.

Still a go. It still has not announced a clinical trial for the COVID-19 vaccine but received money from the Korean government to develop one. If it is announced, then it is going to rocket.

5 ต.ค. 2020

การซื้อขายยังคงดำเนินอยู่

Space elevator~

15 ม.ค. 2021

ปิดการเทรด: ถึงเป้าหมายการตัดขาดทุน

Events didn't pan out as I had expected.

Too bad.